KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Current Assets (2016 - 2025)

Historic Current Assets for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $22.3 billion.

  • Thermo Fisher Scientific's Current Assets fell 625.66% to $22.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 billion, marking a year-over-year decrease of 625.66%. This contributed to the annual value of $22.1 billion for FY2024, which is 997.19% down from last year.
  • As of Q3 2025, Thermo Fisher Scientific's Current Assets stood at $22.3 billion, which was down 625.66% from $24.6 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's 5-year Current Assets high stood at $25.5 billion for Q2 2024, and its period low was $17.7 billion during Q2 2021.
  • Moreover, its 5-year median value for Current Assets was $22.3 billion (2025), whereas its average is $21.9 billion.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Current Assets surged by 3883.66% in 2021, and later plummeted by 2194.22% in 2022.
  • Quarter analysis of 5 years shows Thermo Fisher Scientific's Current Assets stood at $20.1 billion in 2021, then rose by 25.44% to $25.2 billion in 2022, then fell by 2.54% to $24.6 billion in 2023, then dropped by 9.97% to $22.1 billion in 2024, then grew by 0.71% to $22.3 billion in 2025.
  • Its last three reported values are $22.3 billion in Q3 2025, $24.6 billion for Q2 2025, and $23.4 billion during Q1 2025.